A Brief Introduction to PD-1 Antibodies and Immunotherapy | ProSci Incorporated
PD-1: Expanding Beyond Cancer Research | ProSci
JCM | Free Full-Text | Anti-PD-1 and Novel Combinations in the Treatment of Melanoma—An Update
Schematic representation of PD-1 and anti-PD-1/PD-L1 mechanisms of... | Download Scientific Diagram
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Biomolecules | Free Full-Text | The Emerging Role of IL-9 in the Anticancer Effects of Anti-PD-1 Therapy
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study - The Lancet Oncology
Immune responses to tumor-unrelated antigens might predict adverse effects in patients treated with anti-PD-1 immunotherapy | Cellular & Molecular Immunology
The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer: Molecular Therapy
Frontiers | Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer
Current issues and perspectives in PD-1 blockade cancer immunotherapy | International Journal of Clinical Oncology
JCI - TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action - Willsmore - 2021 - European Journal of Immunology - Wiley Online Library
A Surprising Match: Cancer Immunotherapy and Mismatch Repair – NIH Director's Blog
PD-1/L1 e anti-PD-1: test per il dosaggio della molecola e del farmaco – Listarfish.it – PRODOTTI PER RICERCA & DIAGNOSTICA
PD-1
Cancer: anti-PD-1 / PD-L1 antibodies, new solutions for immunotherapy
Biomarkers of response to PD-1 pathway blockade | British Journal of Cancer
Learning from PD-1 Resistance: New Combination Strategies: Trends in Molecular Medicine
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics | Journal of Hematology & Oncology | Full Text
PD-1
Anti-mouse PD-1 (CD279) Antibody | Recombinant RMP1-14 | InvivoGen
PD1 Antibody Selection Tool | Bio X Cell
Efficacy of anti-PD-1 therapy. HCC was induced by HDI of MET/β-catenin.... | Download Scientific Diagram
